Evidence map›Paper›PMID 31987963›Full record

ArticleInternational journal of radiation oncology, biology, physics2020

The Olfactory Bulb Provides a Radioresistant Niche for Glioblastoma Cells.

Cindy R Timme, Charlotte Degorre-Kerbaul, Joseph H McAbee, Barbara H Rath, Xiaolin Wu, Kevin Camphausen, Philip J Tofilon

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Cindy R TimmeRadiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.
Charlotte Degorre-KerbaulRadiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.
Joseph H McAbeeRadiation Oncology Branch, National Cancer Institute, Bethesda, Maryland; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom; Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Barbara H RathRadiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.
Xiaolin WuCancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland.
Kevin CamphausenRadiation Oncology Branch, National Cancer Institute, Bethesda, Maryland.
Philip J TofilonRadiation Oncology Branch, National Cancer Institute, Bethesda, Maryland. Electronic address: philip.tofilon@nih.gov.
National Cancer Institute · USLeidos (United States) · USWake Forest University · US

Funding

Pre-clinical Development of Radiation Sensitizers for Patients with GlioblastomaZIASC010372 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI CAMPHAUSEN, KEVIN · 2009 to 2025
$12.0M
Microenvironmental regulation of glioblastoma radiosensitivityZIABC011372 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TOFILON, PHILIP · 2011 to 2025
$11.7M
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core FacilityZICBC010947 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LAKE, ROSS · 2009 to 2025
$11.0M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA BC011372NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

purposeThe various microenvironments that exist within the brain combined with the invasive nature of glioblastoma (GBM) creates the potential for a topographic influence on tumor cell radiosensitivity. The aim of this study was to determine whether specific brain microenvironments differentially influence tumor cell radioresponse. METHODS AND MATERIALS: GBM stem-like cells were implanted into the right striatum of nude mice. To measure radiosensitivity, proliferation status of individual tumor cells was determined according to the incorporation of 5-chloro-2'-deoxyuridine delivered at 4, 12, and 20 days after brain irradiation. As an additional measure of radiosensitivity, the percentage of human cells in the right hemisphere and the olfactory bulb were defined using digital droplet polymerase chain reaction. Targeted gene expression profiling was accomplished using NanoString analysis.

resultsTumor cells were detected throughout the striatum, corpus callosum, and olfactory bulb. After an initial loss of proliferating tumor cells in the corpus callosum and striatum after irradiation, there was only a minor recovery by 20 days. In contrast, the proliferation of tumor cells located in the olfactory bulb began to recover at 4 days and returned to unirradiated levels by day 12 postirradiation. The percentage of human cells in the right hemisphere and the olfactory bulb after irradiation also suggested that the tumor cells in the olfactory bulb were relatively radioresistant. Gene expression profiling identified consistent differences between tumor cells residing in the olfactory bulb and those in the right hemisphere.

conclusionsThese results suggest that the olfactory bulb provides a radioresistant niche for GBM cells.

Indexed as

Radiation ToleranceAnimalsGlioblastomaMiceOlfactory BulbStem Cell NicheTumor Microenvironment

Identifiers

PMID31987963
PMCPMC7152565
OpenAlexW3002519583

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.